Please login to the form below

Zarzio

This page shows the latest Zarzio news and features for those working in and with pharma, biotech and healthcare.

Clock ticking on biosimilar Enbrel in US

In markets outsider the US - where it is known as Zarzio and has been available since 2006 - Sandoz' drug has captured around a 30% share of the Neupogen market.

Latest news

Novartis launches first biosimilar Zarxio in the US

therapies.”. Biosimilars have been available in Europe since 2006 and Zarxio is already available in more than 40 countries under the brand name Zarzio, where it has captured around 30% of
Apotex latest to file Neupogen biosimilar in the US

the brand name Zarzio.
FDA close to first biosimilar approval

US under the brand name Zarzio.
Biosimilars could make EU big cost savings after slow start

In the case of Amgen's once-daily white blood cell stimulator Neupogen (filgrastim), however, the drug has now been overtaken by its biosimilar rivals - led by Sandoz' Zarzio - and the
FDA 'must publish biosimilar naming guide soon'

as Zarzio - in Europe in 2009. ... According to the company Zarzio is the leading G-CSF in Europe with a 30 per cent market share.

More from news
Approximately 2 fully matching, plus 8 partially matching documents found.

Latest Intelligence

Customer experience rules the digital age

Establishing an effective customer journey
Embracing digital disruption in pharma

LEO Innovation Lab and some of its successes to date

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Swordfish Advertising

Zarzio. Omnitrope. Adoport. Adoport International. Mezolar Matrix. Pain portfolio. Mometasone. Shire Pharmaceuticals.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Editorial Director – Medical Education (MedComms): Neg

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Client Services Director - Med Comms: Great salary and bebefits

Home based, Senior Medical Writer, Medical Communications: Excellent package

Senior Account Manager: Competitive salary commensurate with experience

Home based, Principal Medical Writer, Medical Communications: Excellent package

Delivery Manager/ Head of Delivery – Executive Search: Neg

Client Services Director – Healthcare Advertising - London: Neg

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Healthcare PR Director: £100, 000 – £120, 000 benefits

Home based, Chief Medical Writer, Medical Communications: Excellent package

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Account Manager: £40, 000 - £45, 000 benefits

Business Unit Head, Medical Communications, London: Excellent package

Home based, Editorial Team Leader, Medical Communications: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....